About the Company
We do not have any company description for Fulgent Genetics, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Fulgent Genetics, Inc.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q2 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Fulgent Genetics Q2 2025 Conference Call and Webcast. [Operator Instructions] As a ...
Fulgent Genetics Inc (FLGT) Q2 2025 Earnings Call Highlights: Strong Core Revenue Growth Amid ...
Fulgent Genetics Inc (FLGT) reports a 16% increase in core revenue and expands market reach, despite facing GAAP losses and increased operating expenses.
Fulgent Genetics, Inc. (FLGT) Q1 2024 Earnings Call Transcript
Fulgent Genetics, Inc. (NASDAQ: FLGT) Q1 2024 Earnings Call Transcript May 3, 2024 8:30 AM ET Company Participants Melanie Solomon - IR Ming Hsieh - CEO Brandon Perthuis - CCO Paul Kim - CFO ...
Fulgent Genetics, Inc. (FLGT) Q1 Earnings and Revenues Beat ... - Nasdaq
Written by Zacks Equity Research for Zacks -> Fulgent Genetics, Inc. (FLGT) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.19 per share.
Fulgent Genetics, Inc. (FLGT) Investigation: Bronstein, Gewirtz ...
NEW YORK, NY / ACCESS Newswire / June 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fulgent Genetics, Inc. ("Fulgent" or "the Company ...
Fulgent Announces Second Drug in Development and New Prenatal Genetic ...
Research: A Fulgent lab technician uses a multichannel pipette to dispense a reagent. El Monte-based genetic testing and clinical lab analysis company Fulgent Genetics Inc., which rode the Covid ...
Fulgent Genetics, Inc. (FLGT) Surpasses Q2 Earnings and Revenue Estimates
Fulgent Genetics, Inc. (FLGT) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of a loss of $0.23 per share. This compares to earnings of $0.15 per share a ...
Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue ...
Fulgent Genetics (FLGT) delivered earnings and revenue surprises of 263.16% and 0.46%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Fulgent Genetics, Inc. (FLGT) Q2 2024 Earnings Call Transcript
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q2 2024 Earnings Conference Call August 2, 2024 8:30 AM ETCompany ParticipantsMelanie Solomon - Investor RelationsMing ...
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call Transcript
Fulgent Genetics, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.33. Fulgent Genetics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end ...
Similar Companies
Loading the latest forecasts...